| Schedule of computation of our basic and diluted net loss per share attributable to common shareholders |
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common shareholders for the years ended December 31, 2020, 2019, and 2018 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2020
|
|
2019
|
|
2018
|
|
Basic net loss per share:
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(286,760)
|
|
$
|
(339,170)
|
|
$
|
(239,929)
|
|
Minus: Deemed dividend
|
|
|
—
|
|
$
|
—
|
|
|
7,224
|
|
Minus: Net income attributable to noncontrolling interests
|
|
$
|
—
|
|
$
|
1,847
|
|
$
|
1,362
|
|
Net loss attributable to common shareholders – basic
|
|
$
|
(286,760)
|
|
$
|
(341,017)
|
|
$
|
(248,515)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding – basic and diluted
|
|
|
109,301
|
|
|
79,977
|
|
|
78,564
|
|
Basic net loss per share
|
|
$
|
(2.62)
|
|
$
|
(4.26)
|
|
$
|
(3.16)
|
|
Diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(286,760)
|
|
$
|
(339,170)
|
|
$
|
(239,929)
|
|
Minus: Deemed dividend
|
|
|
—
|
|
$
|
—
|
|
|
7,224
|
|
Minus: Net income attributable to noncontrolling interests
|
|
$
|
—
|
|
$
|
1,847
|
|
$
|
1,362
|
|
Minus: Gain on liability-classified warrants
|
|
$
|
—
|
|
|
8,132
|
|
|
—
|
|
Net loss attributable to common shareholders – diluted
|
|
$
|
(286,760)
|
|
$
|
(349,149)
|
|
$
|
(248,515)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding – basic and diluted
|
|
|
109,301
|
|
|
79,977
|
|
|
78,564
|
|
Diluted net loss per share
|
|
$
|
(2.62)
|
|
$
|
(4.37)
|
|
$
|
(3.16)
|
|
| Schedule of anti-dilutive securities were not included in the computation of diluted shares outstanding |
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive, or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2020
|
|
2019
|
|
2018
|
|
Common Stock Warrants
|
|
19,933
|
|
3,370
|
|
3,366
|
|
Series D Preferred Stock Warrants
|
|
—
|
|
485
|
|
9,090
|
|
Series E Preferred Stock Warrants
|
|
—
|
|
121
|
|
—
|
|
RSUs
|
|
46,525
|
|
22,758
|
|
912
|
|
Options
|
|
24,158
|
|
36,609
|
|
44,066
|
|
Unvested Shares from Early Exercise
|
|
57
|
|
187
|
|
1,120
|
|
Restricted Shares
|
|
2,148
|
|
3,689
|
|
2,994
|
|
Redeemable convertible preferred stock
|
|
—
|
|
314,424
|
|
271,490
|
|
Total anti-dilutive securities
|
|
92,821
|
|
381,643
|
|
333,038
|
|